RM Partners is one of 21 Cancer Alliances established by NHS England to lead on the delivery of the cancer care recommendations in the NHS Long Term Plan. Our mission is to increase the number people living for 5 years or more following a cancer diagnosis; and increase the number of people diagnosed with early-stage disease.
We will do this by diagnosing people earlier and faster to improve survival; eliminating variation and inequalities; optimising care through innovation and improvement; and improving patient experience and quality of life.
We work collaboratively with our stakeholders, including the two Integrated Care Systems that we cover (north west London and south west London) and our partner NHS hospital Trusts and primary care partners, to deliver excellent cancer care for our population of 3.8 million people across west London.
Our programme of work is overseen by our governance groups:
- our Executive Board, made up of Trust chief executive and senior officers, as well as Integrated Care System (ICS), medical and primary care leads
- our Clinical Oversight Board, consisting of senior clinical, nursing and operational representatives from each of our partner Trusts, as well as primary care leads and commissioning colleagues
- the North West London and South West London Cancer Boards, which through clinical, nursing, primary care and operational representation focuses on more localised cancer performance, transformation and issues.
As an established Cancer Alliance with a track record of delivery, we contribute to the National Cancer Programme and support other Cancer Alliances by sharing our work and learning. The aim over the coming years is to continue to deliver our vision of working in partnership to achieve world-class cancer outcomes for the population we serve. We work to reduce variation in outcomes and access, to improve survival and quality of life for our population.
Our priorities are consistent with those of our constituent Integrated Care Systems in north west London and south west London, and our programmes of work to deliver world class cancer services are aligned.